180 Life Sciences – Clinical Programs
James (Jim) Woody, CEO of 180 Life Sciences Corp., a newly formed clinical-stage biotech company focused on novel drugs for unmet needs in inflammatory ...
5306 articles
James (Jim) Woody, CEO of 180 Life Sciences Corp., a newly formed clinical-stage biotech company focused on novel drugs for unmet needs in inflammatory ...
Gail McIntyre, CEO of Aravive, Inc., discusses the urgent need for improved therapeutic approaches to treat patients with ovarian cancer who are resista...
Returning guest, Jon Friis, founder and CEO of MIIskin, the most popular consumer skin tracking platform in the world (500,000 users), and a partner of ...
William Sandborn, MD, Chief of Gastroenterology, Professor of Medicine, University of California, San Diego, discusses positive study results in Crohn's...
Diane Newman, urologic nurse practitioner from the University of Pennsylvania Penn Center for Continence and Pelvic Health, Division of Urology discusse...
Luis Raez, Chief Scientific Officer and Medical Director, Memorial Cancer Institute/Memorial Health Care System in Pembroke Pines, Florida, discusses a ...
Gary Lelli, Associate Professor of Ophthalmology at Weill Cornell Medical College discusses the first annual Thyroid Eye Disease (TED) Awareness Week (N...
Andrea Russo, MD, Director of Electrophysiology and Arrhythmia Services at Cooper University Hospital discusses the 50% decrease in in-person primary ca...
Irina Anselm, MD, Director of the Mitochondrial Program and Co-Director of the Neurometabolic Program at Boston Children's Hospital discusses the ultra ...
LeRoy Graham, MD, Founder and Medical Director of Not One More Life Asthma Care Program discusses a new project to address health disparities among peop...